IP Library Granted Patent US 9,233,954
Granted Patent B2
US 9,233,954 · App. 13/979,931 · Granted Jan 12, 2016

Organic amine salts of Azilsartan, preparation method and use thereof

Inventors: Bigao Pan (Jiangsu, CN); Longbin Huang (Jiangsu, CN); Baohai Yang (Jiangsu, CN)
Assignees: Jiangsu Hansoh Pharmaceutical Co., Ltd.; Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Jiangsu Hansoh Medicine Institute Co., Ltd.
C07D413/10A61K31/4245C07C213/08C07C215/08C07C215/40C07D295/088
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,233,954
App. No.
13/979,931
Granted
Jan 12, 2016
Kind
B2
Abstract

Disclosed are organic amine salts of azilsartan, a preparation method and use thereof. In particular, disclosed are organic amine salts of azilsartan, their preparation method, the pharmaceutical composition comprising the compound in a therapeutically effective quantity, and their use for the manufacture of antihypertensive medicaments.

Claims (15)

1. An organic amine salt of Azilsartan, wherein the ratio of Azilsartan to organic amine is m:1 and m is an integer selected from 2 to 10.

2. The organic amine salt of Azilsartan according to claim 1 , wherein the ratio of Azilsartan to organic amine is 2:1.

3. The organic amine salt of Azilsartan according to claim 1 , wherein the organic amine is selected from the group consisting of methylamine, dimethylamine, trimethylamine, ethylamine, diethylamine, triethylamine, ethanolamine, piperazine, dibenzylethylenediamine, meglumine, tromethamine, tetramethyl quaternary ammonium, tetraethyl quaternary ammonium and choline.

4. The organic amine salt of Azilsartan according to claim 3 , having formula (I) or (II), wherein M is an organic amine selected from the group consisting of methylamine, dimethylamine, trimethylamine, ethylamine, diethylamine, triethylamine, ethanolamine, piperazine, dibenzylethylenediamine, meglumine, tromethamine, tetramethyl quaternary ammonium, tetraethyl quaternary ammonium and choline,

and n is an integer greater than 1.

5. The organic amine salt of Azilsartan according to claim 3 , having formula (III) or (IV):

wherein n is an integer greater than 1.

6. A process for preparing the organic amine salt of Azilsartan according to claim 1 , comprising adding Azilsartan acid and an organic amine respectively into an alcoholic organic solvent at room temperature or under heating to obtain the salt.

7. A process for preparing the organic amine salt of Azilsartan of formula (III) according to claim 5 , the process comprising adding Azilsartan acid and a choline alcohol solution into an alcoholic organic solvent.

8. The process according to claim 6 , wherein the alcoholic organic solvent is selected from the group consisting of methanol, ethanol, propanol and isopropanol.

9. A pharmaceutical composition for the treatment of hypertension, comprising a therapeutically effective amount of the organic amine salt of Azilsartan according to claim 1 as an active ingredient and a pharmaceutically acceptable carrier.

10. The process according to claim 6 , being conducted under an anhydrous condition.

11. The process according to claim 7 , wherein the choline alcohol solution is a choline methanol solution containing 45% (by weight) choline.

12. The process according to claim 7 , wherein the molar ratio of Azilsartan to choline is 1:1 to 2:1.

13. A method of treating hypertension in a subject in need thereof, comprising administering to the subject a pharmaceutical composition according to claim 9 .

Assignments (2)
CHANGE OF NAME Recorded Jun 29, 2018
From: JIANGSU HANSOH PHARMACEUTICAL CO., LTD.
To: JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD.
Reel/Frame 046465/0547 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2013
From: PAN, BIGAO; HUANG, LONGBIN; YANG, BAOHAI
To: JIANGSU HANSOH PHARMACEUTICAL CO., LTD.; JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD.; JIANGSU HANSOH MEDICINE INSTITUTE CO., LTD.
Reel/Frame 030806/0971 →
Priority Claims (1)
CN 2011 1 0022311 · Jan 20, 2011 · national
Continuity (1)
Related Publication 20130296334A1 · Nov 7, 2013